Precursor Lymphoid Neoplasm — Trials

Precursor Lymphoid Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,154 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 567
Recruiting: 344
Ph III recruiting: 27
Growth YoY: −13.4%
Industry share: 13%
Top sponsor: City of Hope Medical Center
Termination share: 33.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (286)

clinicaltrialsPublishedShowing 401–450 of 661 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07366801	Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies	recruiting	Phase 2 / Phase 3	64	Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyOTHER	1	Jan 26, 2026	clinicaltrials
NCT03642626	MT2017-45: CAR-T Cell Therapy for Heme Malignancies	active not recruiting	Phase 2	150	Masonic Cancer Center, University of Minnesota